EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Volume 14 Issue 6

Recent FDA Advancements in Rare Diseases – Funding, Partnerships, and Programs

The paucity of therapeutic choices is a reality often acknowledged by the US Food and Drug Administration (FDA) as it reviews applications for new medical products or...
30 November 2022 Volume 14 Issue 6 applications | approved
Continue Reading →
Volume 14 Issue 6

Impact of Electronic Signature Towards Clinical Trial Agreements

The use of electronic signatures is desirable for companies nowadays as technology has growingly become an integral part of our life. Not only that, implementing it c...
30 November 2022 Volume 14 Issue 6 Agreements | clinical
Continue Reading →
Volume 14 Issue 6

Taking a Long-Term Approach to Improving Vaccine Trial Recruitment

The groundbreaking mRNA technology used in the COVID-19 vaccine has potential applications in preventing a number of other infectious diseases and is ushering in a wa...
30 November 2022 Volume 14 Issue 6 cost | COVID
Continue Reading →
Volume 14 Issue 6

Improving Clinical Study Publishing Success

Academic publishing is highly competitive, and this competition is only growing as more and more research papers are being submitted to top journals – submissions to ...
30 November 2022 Volume 14 Issue 6 clinical | competitive
Continue Reading →
Volume 14 Issue 6

Beyond Pill Count: Challenging the Status Quo for Medication Adherence in Clinical Trials

Poor adherence to the investigational product can bring even the most carefully planned clinical trial to its knees. It is time to accept that traditional approaches ...
30 November 2022 Volume 14 Issue 6 Adherence | medication
Continue Reading →
Volume 14 Issue 6

Learning From The Past

How Sharing Clinical Science Research During the Pandemic has better Prepared Us for The Future “The scientific community working together can do some pretty amazing...
30 November 2022 Volume 14 Issue 6 approved | conclusion
Continue Reading →
Volume 14 Issue 6

The Future of Clinical Research in Ukraine

Ukraine is currently experiencing difficult times due to an unprovoked act of aggression from a neighbor. As a country with 40 million+ inhabitants, it has tremendous...
30 November 2022 Volume 14 Issue 6
Continue Reading →
Volume 14 Issue 6

Central Europe – Look Behind the Curtain of Trials for On The Ground Knowledge

In the last 5–10 years we have seen global sponsors and global CROs increasingly looking to open investigator sites or acquire resources in Central and Eastern Europe...
30 November 2022 Volume 14 Issue 6
Continue Reading →
Volume 14 Issue 6

mRNA Vaccine Applications in Global Health: Promise and Challenges

The global COVID-19 pandemic has focused intense attention on the potential benefits and continuing challenges of vaccine development. In the twentieth century, a lar...
30 November 2022 Volume 14 Issue 6
Continue Reading →
Volume 14 Issue 6

Assent Is Not Just for Children

Requirements and Best Practices for Assent in Clinical Research Informed consent requires that prospective participants receive sufficient information about a researc...
30 November 2022 Volume 14 Issue 6
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte